Media Center
Press Releases

Press Releases

19 Jan 17
Asia-Pacific seasonal influenza vaccines market to surpass $1.7 billion by 2022, says GBI Research

The seasonal influenza market across the Asia-Pacific (APAC) region, which includes India, China, Australia, South Korea and Japan, is forecast to grow from $1.24 billion in 2015 to $1.71 billion by 2022, at a compound annual growth rate of 4.7%, according to business intelligence provider GBI Research.

Read post
12 Jan 17
Currently underserved melanoma therapeutics space offers promising pipeline, with 226 first-in-class programs, says GBI Research

The melanoma pipeline has 579 programs active across all stages of development, with 226 first-in-class programs in the pipeline, acting on 138 distinct first-in-class molecular targets. This accounts for 38% of all programs with a disclosed molecular target and reflects the high degree of innovation in this indication, according to business intelligence provider GBI Research.

Read post
10 Jan 17
Asia-Pacific chronic obstructive pulmonary disease market set to hit $7.3 billion by 2022, says GBI Research

The chronic obstructive pulmonary disease (COPD) market in the Asia-Pacific (APAC) is forecast to almost double from $3.7 billion in 2015 to $7.3 billion by 2022, representing a compound annual growth rate of 10.2%, according to business intelligence provider GBI Research.

Read post
21 Dec 16
Low innovation in hepatitis C therapies means significant unmet needs remain, says GBI Research

Although recent years have seen a revolution in the hepatitis C space, as interferon-free direct-acting antiviral (DAA) combination therapies have started replacing interferon-based therapies, a number of considerable unmet needs remain, according to business intelligence provider GBI Research.

Read post
14 Dec 16
Cancer immunotherapies space to witness extraordinary growth, reaching $75.8 billion by 2022, says GBI Research

The market size for cancer immunotherapies is expected to grow more than fourfold from $16.9 billion in 2015 to $75.8 billion by 2022, representing a rapid compound annual growth rate (CAGR) of 23.9%, according to business intelligence provider GBI Research.

Read post